Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s AccuraSee intraocular lens has completed an early feasibility study in post-cataract patients and received FDA approval for a Phase I trial targeting age-related macular degeneration. The product aims to restore or improve vision in patients with significant visual impairment after cataract surgery or due to AMD. A larger multi-site clinical study with up to 350 patients was planned as of late 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OnPoint Vision.